-
Featured
Interventional Cardiology Studies Boost Safety in TAVR, PCI
A Massachusetts General Hospital interventional cardiologist is using research to lower bleeding risk and incidence of stroke in percutaneous coronary intervention and transcatheter aortic valve replacement.
-
Aortic Valve Replacement Substantially Underutilized for Severe Aortic Stenosis
Shawn X. Li, MD, MBA, Sammy Elmariah, MD, MPH, and colleagues warn that the marked and rapid growth in the annual volume of aortic valve replacements being performed has been paralleled by equally rapid growth in the number of patients with severe aortic stenosis and an indication for the procedure.
-
Studies Investigate Transfemoral Mitral Valve Replacement
Massachusetts General Hospital is among the first in the U.S. to perform two different novel transfemoral mitral valve replacement procedures to treat mitral regurgitation.
-
Cerebral Embolic Protection Device May Not Reduce Stroke Risk After Transcatheter Aortic Valve Implantation
Dhaval Kolte, MD, PhD, and Sammy Elmariah, MD, MPH, and colleagues determined from a nationally representative database that using a cerebral embolic protective device during transcatheter aortic valve implantation was not associated with lower rates of in-hospital stroke, transient ischemic attack or mortality.
-
Advancing Complex Coronary Artery Disease Interventions
Massachusetts General Hospital interventional cardiologists are studying best practices and novel therapeutics to better manage complex coronary artery disease patients.
-
TAVR Team Continuously Innovating to Treat Aortic Stenosis
Massachusetts General Hospital researcher-clinicians have improved transcatheter aortic valve replacement (TAVR) to make it available to all patients with aortic stenosis.
Interventional Cardiology Contributors
-
Darshan Doshi, MD
Interventional Cardiologist, Massachusetts General Hospital
Recent Article
Advancing Complex Coronary Artery Disease Interventions
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
-
Nathaniel Langer, MD, MSc
Cardiac Surgeon, Surgical Director, Lung Transplant Program, Massachusetts General Hospital, Assistant Professor of Surgery, Harvard Medical School
Recent Article
Transforming the Future of Lung Transplantation by Improving Access and Outcomes
-
Rahul Sakhuja, MD
Interventional Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital
Recent Article
Interventional Cardiology Studies Boost Safety in TAVR, PCI
-
Serguei Melnitchouk, MD, MPH
Cardiac Surgeon, Co-Director, Heart Valve Program, Quality Director, Division of Cardiac Surgery
Recent Article
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.